The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Neomycin and Polymyxin B Sulfates and Hydrocortisone
neomycin sulfate, polymyxin b sulfate and hydrocortisone · NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL · Suspension · Auricular (Otic) · Proficient Rx LP
NDC 63187-0648-10 · 10 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 61314-0641-75) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$16.86per unit
middle half $13.82–$18.71 · 4,646 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $16.86
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
85%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for neomycin sulfate, polymyxin b sulfate and hydrocortisone (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Proficient Rx LPUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA062488
- TE code
- AT
- Approval date
- Nov 6, 1985
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of neomycin sulfate, polymyxin b sulfate and hydrocortisone (Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Proficient Rx LP | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Sandoz Inc | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Sandoz Inc. | NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL; HYDROCORTISONE 10 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Preferred Pharmaceuticals Inc. | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Proficient Rx LP | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Sandoz Inc | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Sandoz Inc. | NEOMYCIN SULFATE 10 mg/mL; POLYMYXIN B SULFATE 3.5 mg/mL; HYDROCORTISONE 10000 [USP'U]/mL | Jul 22, 2026 | Aug 19, 2026 |
| A-S Medication Solutions | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Bryant Ranch Prepack | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Preferred Pharmaceuticals Inc. | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Proficient Rx LP | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Sandoz Inc | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Sandoz Inc. | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Neomycin and Polymyxin B Sulfates and Hydrocortisone — NDC 63187-0648-10," retrieved September 3, 2026, https://drugdashboards.com/drug/63187064810.
Free to cite with attribution — see how the data is put together.